Anti SLC22A2 pAb (ATL-HPA008567 w/enhanced validation)

Catalog No:
ATL-HPA008567-25
$360.00
Application: IHC 
Clonality: Polyclonal 
Host: Rabbit 
Reactivity: Human 
Protein Description: solute carrier family 22 (organic cation transporter), member 2
Gene Name: SLC22A2
Alternative Gene Name: OCT2
Isotype: IgG
Interspecies mouse/rat: ENSMUSG00000040966: 84%, ENSRNOG00000016625: 77%
Entrez Gene ID: 6582
Uniprot ID: O15244
Buffer: 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative.
Storage Temperature: Store at +4°C for short term storage. Long time storage is recommended at -20°C.

Cognate Antibody/Antigen for Anti SLC22A2 pAb (ATL-HPA008567 w/enhanced validation)
Antibody Anti SLC22A2 pAb (ATL-HPA008549 w/enhanced validation)
Antigen PrEST Antigen SLC22A2 (ATL-APrEST86074)
Documents & Links for Anti SLC22A2 pAb (ATL-HPA008567 w/enhanced validation)
Datasheet Anti SLC22A2 pAb (ATL-HPA008567 w/enhanced validation) Datasheet (External Link)
Vendor Page Anti SLC22A2 pAb (ATL-HPA008567 w/enhanced validation) at Atlas

Documents & Links for Anti SLC22A2 pAb (ATL-HPA008567 w/enhanced validation)
Datasheet Anti SLC22A2 pAb (ATL-HPA008567 w/enhanced validation) Datasheet (External Link)
Vendor Page Anti SLC22A2 pAb (ATL-HPA008567 w/enhanced validation)

Citations for Anti SLC22A2 pAb (ATL-HPA008567 w/enhanced validation) – 7 Found
Metformin Accumulation Correlates with Organic Cation Transporter 2 Protein Expression and Predicts Mammary Tumor Regression In Vivo.
Cancer Prev Res (Phila). 2017 Mar;10(3):198-207. doi: 10.1158/1940-6207.CAPR-16-0211-T. Epub 2017 Feb 2.  PubMed
Direct effects of metformin in the endometrium: a hypothetical mechanism for the treatment of women with PCOS and endometrial carcinoma.
J Exp Clin Cancer Res. 2014 May 11;33(1):41. doi: 10.1186/1756-9966-33-41.  PubMed
Reversing the reduced level of endometrial GLUT4 expression in polycystic ovary syndrome: a mechanistic study of metformin action.
Am J Transl Res. 2015 Mar 15;7(3):574-86. eCollection 2015.  PubMed
Upregulation of miR-489-3p and miR-630 inhibits oxaliplatin uptake in renal cell carcinoma by targeting OCT2.
Acta Pharm Sin B. 2019 Sep;9(5):1008-1020. doi: 10.1016/j.apsb.2019.01.002. Epub 2019 Jan 8.  PubMed
The failure of DAC to induce OCT2 expression and its remission by hemoglobin-based nanocarriers under hypoxia in renal cell carcinoma.
Theranostics. 2020 Feb 18;10(8):3562-3578. doi: 10.7150/thno.39944. eCollection 2020.  PubMed
Farnesoid X Receptor Activation Stimulates Organic Cations Transport in Human Renal Proximal Tubular Cells.
Int J Mol Sci. 2020 Aug 24;21(17):6078. doi: 10.3390/ijms21176078.  PubMed
Exacerbation of Cisplatin Cellular Toxicity by Regulation of the Human Organic Cation Transporter 2 through Angiotensin II.
Int J Mol Sci. 2022 Dec 14;23(24):15866. doi: 10.3390/ijms232415866.  PubMed